



After being indexed in 2006 in EMBASE/Excerpta Medica and Scopus, and later in Science Citation Index Expanded and Journal Citation Reports/
Science Edition citation databases, Biochemia Medica launched a new web page and online manuscript submission system in 2010, and celebrated 
its fi rst Impact Factor in the same year. Now, starting from the end of the 2011, the journal will also be indexed in PubMed/Medline, and this will 
contribute to increase the journal’s exposure and accessibility worldwide. This is an important breakthrough, which is expected to further increase 
the popularity of the journal, as well as the submission rate and citations. Although several tools are currently available as Web resources to retrieve 
scientifi c articles, whose functioning and basic criteria are thought to be rather similar, the functionality, coverage, notoriety and prominence may 
diff er widely. The recent indexing of Biochemia Medica in PubMed/Medline has thereby given us the opportunity to provide a timely update on bio-
medical research platforms, their relationship with article submissions and journal rankings.
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After initially being indexed in 2006 in EMBASE/
Excerpta Medica and Scopus (1), and later in Sci-
ence Citation Index Expanded and Journal Citation 
Reports/Science Edition citation databases (2), Bio-
chemia Medica launched a new web page and on-
line manuscript submission system in 2010 (3), and 
celebrated its fi rst Impact Factor in the same year 
(4). Beginning November 23, 2011 Biochemia Medi-
ca is now also indexed in PubMed/Medline, and 
this will contribute to increase the journal’s expo-
sure and accessibility worldwide. This is expected 
to further increase the journal’s Impact Factor val-
ue, which last year remarkably increased from 
0.660 to 1.085, whilst those of most other labora-
tory medicine journals has instead declined (5). 
The above factors represent major breakthroughs 
for Biochemia Medica, and have provided the op-
portunity to provide an update on biomedical re-
search platforms and their relationship with article 
submissions and journal rankings.
Biomedical research platforms
Several tools are currently available as Web re-
sources to retrieve scientifi c articles. Although the 
basic concepts underlying the diff erent biomedi-
cal research platforms are similar, the functionality, 
coverage, notoriety and prominence may diff er 
widely (Table 1). Some of the most representative 
will be briefl y discussed in the following section.
PubMed/Medline
PubMed, conventionally known also as “Medline”, 
contains so far more than 21 million citations for 
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biomedical literature from Medline, life science 
journals as well as online books. PubMed is man-
aged by the U.S. National Library of Medicine 
(NLM), which is the world’s largest medical library. 
PubMed provides access to bibliographic informa-
tion that includes Medline citations (a database 
that contains citations from the late 1940s to the 
present, with additional older material), as well as 
articles on plate tectonics or astrophysics from cer-
tain Medline journals (usually general science and 
chemistry journals, for which the life sciences arti-
cles are indexed for Medline), citations made avail-
able before the date that the journal was selected 
for indexing as well as additional life science jour-
nals that submit full text to PubMed Central and 
receive a qualitative review by NLM. Basically, cita-
tions may include links to full-text content also 
from PubMed Central and publisher web sites. 
Once the key concepts for the search have been 
identifi ed, these can be entered in the search box 
as a general medical query, one or more keywords, 
authors’ name (author’s last name plus initials 
without punctuation) and and/or journals (journal 
name or abbreviation). The special Clinical Study 
Categories search fi lters are useful to limit retrieval 
to citations of articles reporting studies carried out 
with specifi c methodologies (e.g., applied clinical 
research). Citations are fi rst shown as 20 items per 
page, the most recently entered citations being 
ranked fi rst. The output of the search is initially dis-
played in a summary format, but by clicking on the 
title of the article the abstract can be visualized, 
when this is available. Moreover, although the 
search result in most cases does not include the 
full text of the journal article (exceptions are free 
full text articles available in PubMed Central), the 
abstract display of the citation usually provides a 
link to the full text, typically from the publisher’s 
web site. The Medical Subject Headings (MeSH) is 
the NLM controlled vocabulary thesaurus used for 
indexing PubMed citations, which can also be 
used to fi nd terms such as subheadings, publica-
tion types, supplementary Concepts and pharma-
cological actions. The search result can also be or-
dered according to specifi c parameters such as 
date of publication, relevance, authors, source title 
and type of article. To comply with the increasing 
diff usion of medical and scientifi c applications for 
smartphones (6), the PubMed text version is also 
designed to work with a variety of handheld, Palm 
Powered and Pocket PC handheld computers. In 
particular, PubMed Mobile has the same search 
functionality and content as the typical Web ver-
sion and all search terms and fi elds work identical-
ly. Interestingly, daily HTML feeds can also be easily 
set up with specifi c MeSH or keywords. PubMed 
has also an interesting “spin-off ”, i.e., Pubfocus, 
which performs statistical analysis of the PubMed/
Medline searches enriched with additional infor-
mation, gathered from journal rank database and 
forward referencing database.
ISI Web of Science
Thomson Reuters (formerly Institute for Scientifi c 
Information - ISI) Web of Knowledge is a premier 
research platform for information in the sciences, 
social sciences, arts, and humanities. The specifi c 
subsection “Web of Science” provides researchers, 
List of medical and scientifi c search engines
PubMed/MEDLINE. Available at:
http://www.ncbi.nlm.nih.gov/pubme - d
ISI Web of Science. Available at:
https://www.isiknowledge.com -  
Scopus SciVerse. Available at:
http://www.info.sciverse.com/scopu - s
Google Scholar. Available at: 
http://scholar.google.it - /
Journal / Author Name Estimator (JANE). Available at:
http://www.biosemantics.org/jane - /




BioMed Central. Available at:
http://www.biomedcentral.co - m.










TABLE 1. List of medical and scientifi c search engines.
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administrators, faculty, and students with quick, 
powerful access to the world’s leading citation da-
tabases, covering over 10,000 of the highest im-
pact journals worldwide, including Open Access 
journals and over 110,000 conference proceedings. 
Current and retrospective coverage in the scienc-
es, social sciences, arts, and humanities are cov-
ered since the 1900s. The most useful search fi elds 
include topic, titles, authors, researcher ID, publi-
cation name, and document type. The search out-
put is fi rst shown as an abbreviated record format, 
including at the top of the page the selected time-
span and any selected data restrictions such as 
document types and languages. Additional inter-
esting tools include the “citing articles count” (i.e., 
the total number of citations for all citation data-
bases and all years in the all databases search func-
tion in Web of Science or BIOSIS Citation Index), 
and “cited articles” (which is a list of all documents 
cited by the article whose title appears at the top 
of the page and that can then be displayed by di-
rectly clicking on them). There is also a link availa-
ble that displays the abstract of the record in a 
scrolling box. At variance with PubMed, Web of 
Science is not free and can hence be accessed only 
via institution’s remote access proxy, Athens au-
thentication or signing in with Web of Knowledge 
username and password.
Scopus SciVerse
As stated in the offi  cial website, launched in No-
vember 2004, SciVerse Scopus is one of the largest 
abstract and citation databases of peer-reviewed 
literature and quality web sources worldwide. The 
database, which requires Athens or other Institu-
tion login to fully benefi t from the content, cur-
rently contains 46 million records (25 million with 
references back to 1996, 21 million records pre-
1996 which go back as far as 1823, as well as 4.8 
million conference papers from proceedings and 
journals), 70% of which contain abstracts, covering 
nearly 19,500 titles (i.e., 18,500 peer-reviewed jour-
nals including 1,800 Open Access journals, 425 
trade publications, 325 book series and 250 con-
ference proceedings) from 5,000 publishers. The 
database also provides full Medline coverage. The 
functionality of the database includes a simple and 
intuitive interface, the link to full-text articles and 
other library resources, an author Identifi er to au-
tomatically match an author’s published research 
including the h-index, a citation tracker to simply 
fi nd citations in real-time and HTML feeds. The ba-
sic search can be carried out directly from the 
homepage, whereas the advanced search uses 
Boolean operators for title, abstract, author key-
word, index keywords and author fi elds. The re-
sults are displayed in a tabular format that can be 
easily sorted according to various parameters (e.g., 
date, relevance, authors, source title and number 
of citations) and contains additional information 
besides those available in other scientifi c search 
engines such as h-index and citations to the mate-
rial retrieved. Likewise Pubed/Medline, an iPhone 
application of Scopus SciVerse is also available.
Google Scholar
This completely free search engine provides a very 
simple mean - possibly the easiest among all re-
search platforms - to broadly access scholarly and 
biomedical literature. A huge number of disci-
plines can be searched, including articles, theses, 
books, abstracts and court opinions, from a variety 
of sources such as academic publishers, profes-
sional societies, online repositories, universities 
and other websites. The result of the search does 
not provide a direct access of the material (e.g., an 
article), which can however be further accessed 
through libraries or alternative web resources such 
as the journal’s or publisher’s web site. The docu-
ments retrieved are ranked weighing the full text, 
where it was published, by who it was written, as 
well as how often and how recently it has been cit-
ed in other scholarly literature (Google Scholar 
sources). When multiple versions of a document 
are indexed, the full and authoritative text from 
the publisher is selected as the primary version. 
There is also a strict collaboration with the publish-
ers, to maintain control over access to the content 
of the document.
Journal / Author Name Estimator (JANE)
The Journal / Author Name Estimator (JANE) is a 
peculiar but very useful research platform, with 
less coverage but several appealing features for 
scientists. JANE uses the open source search en-
gine Lucene. The keywords that can be introduced, 
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which include titles and/or abstracts of the articles, 
are parsed using the MoreLikeThis parser class. The 
engine fi rst searches for the 50 articles that are 
most similar to what has been input. For each of 
these articles, a similarity score between that arti-
cle and the text to be searched is calculated. The 
similarity scores of all articles belonging to a cer-
tain journal or author are then summed to calcu-
late the “confi dence” score for that journal or au-
thor and the fi nal results are classifi ed according to 
this index. All journals indexed in Medline are in-
cluded, although those for which no entry was 
found in Medline in the last year are not shown. All 
authors that have published Medline articles over 
the past 10 years are also included in Jane. Only 
regular articles are displayed, i.e., full articles, short 
communication and reviews, whereas comments, 
editorials, historical articles, congresses, practice 
guidelines are excluded. After entering the text of 
the title or the abstract of an article, JANE is very 
helpful in ascertaining whether similar articles are 
already published in Medline and, eventually, 
which is the most appropriate journal to submit 
the work.
Impact factor: the good, the bad and the 
ugly!
The concept of using citations to gauge the impor-
tance of journal is not new, since it was originally 
conceived by Eugene Garfi eld in 1955, and further 
defi ned as “Impact Factor” (7). Five years later, Gar-
fi eld himself funded the ISI (i.e., Institute for Scien-
tifi c Information), which is now managed by Thom-
son Reuters. The basic concept underlining the im-
portance of the Impact Factor is that articles that 
are highly cited by other articles may be consid-
ered more important than those that are scarcely 
cited. To prevent the bias of time in the estimation 
of this measure, the Impact Factor is thereby calcu-
lated using two particular elements, namely (i) the 
number of citations in the current year to items 
published in the previous two years at the numer-
ator and (ii) the number of substantive publica-
tions in the same two years at the denominator. 
The 2010 Impact Factor of a certain journal will 
hence be calculated as follows:
number of citations in 2010 to items
published in the journal in 2009 and 2008 /
number of items published in the 
same journal in 2009 and 2008.
Currently, the higher a journal’s Impact Factor, the 
more infl uential that journal is considered to be.
There are, however, several limitations to all of the 
searchable databases as well as any of the ‘quality’ 
metrics used, including the Impact Factor (Table 2) 
(8,9).
Top 10 limitations to searchable databases and ‘quality’ 
metrics such as the Impact Factor
Accessibility of database, availability of journals and 1. 
journal listing bias.
Inference, not always valid, that high citation rates refl ect 2. 
the ‘high quality’ of an article.
Inference, not always valid, that a high IF refl ects 3. 
generalized high citation rates or generalized ‘high quality’ 
for the journal.
Citation bias (self citations from journals and authors).4. 
Citations have equal ranking.5. 
Specialty bias for Impact Factor.6. 
Date of publication bias.7. 
High quality articles, and high quality journals, directed 8. 
at end-users or medical and scientifi c practitioners, rather 
than researchers per se, may have low Impact Factors.
The impact factor is calculated over a relatively short 9. 
period of time (two years), whereas the life of published 
papers is much longer than this (10 or more years).
The Impact Factor is very easy to manipulate and 10. 
artifi cially infl ate.
TABLE 2. Top 10 limitations to searchable databases and ‘qual-
ity’ metrics such as the Impact Factor.
First, there is the accessibility of the databases, the 
availability of the journals and individual journal 
listing biases. The least accessible database is the 
Thomson Reuters (formerly ISI) Web of Science. 
Journals may require subscriptions or charge an 
article access fee. Only journals listed in each spe-
cifi c database are included in each analysis. For ex-
ample, for Scopus (which is managed by Elsevier), 
there is a possible publisher bias; for the Web of 
Science, database listings strongly favor English 
language journals and primarily those published 
in the U.S.; other databases would have similar re-
strictions and possible biases.
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Second, the concept that high citation rates refl ect 
the ‘high quality’ of an article is not always valid. 
Although probably true in most cases, an article 
may have a high citation rate due to ongoing cita-
tion of some scientifi c fl aw.
Third, there is the inference that a high Impact Fac-
tor refl ects generalized high citation rates or gener-
alized ‘high quality’ for the journal, and again this 
may not be valid. In fact, a journal’s Impact Factor 
refl ects each journal article’s citation pattern, and 
there exists a wide range of citation patterns for dif-
ferent articles published within any given journal. 
Also, article citation rates determine the journal’s 
Impact Factor, not the other way around.
Fourth, there are possible citation biases evident, 
as there are no correction factors applied against 
the infl uence of self-citation in Impact Factor cal-
culations, and both authors and journals may favor 
self-citation.
Fifth, all citations have equal ranking, and there is 
no adjustment for where citations appear. There-
fore, a citation from a ‘low impact’ journal is count-
ed equally to a citation from a ‘high impact’ journal.
Sixth, there is a specialty bias to consider – Impact 
Factors diff er according to the research or special-
ty fi eld. It is thereby less generally valid to compare 
Impact Factors between journals from diff erent 
specialty fi elds.
Seventh, the date of publication issues infl uences 
the “citability” of any given paper; i.e. papers pub-
lished at the beginning of the year contribute to 
Impact Factor calculations more than those pub-
lished at the end of the year because they are in 
press for a longer period of time.
Eighth, some high quality articles, and high quality 
journals, are directed at end-users or medical and 
scientifi c practitioners, rather than researchers per 
se. These end-user directed papers from such jour-
nals may have low citation rates and thus low Im-
pact Factor values (i.e., educational reviews or oth-
er papers aimed at medical and/or laboratory 
practitioners rather than scientifi c researchers will 
be cited less frequently in future publications and 
therefore will not contribute to the journal’s Im-
pact Factor – in fact they will likely act to reduce 
the journal’s Impact Factor although these should 
still be considered very important items). Thus, al-
though considered an important aspect of usage, 
the Impact Factor only refl ects a very small level of 
journal and article usage or utility (8). Indeed, this 
becomes rather striking when undertaking any 
diff erential analysis of papers published within a 
journal and refl ecting on citation rates contribut-
ing to the journal’s Impact Factor versus the popular-
ity of articles as identifi ed by online downloads. Rath-
er simply, the separate listings contain some articles 
which appear in both, but most articles appearing in 
one list do not appear in the other (10,11).
Ninth, the Impact Factor is calculated over a rela-
tively short period of time (two years), whereas the 
life of published papers is much longer (10 or more 
years). Indeed, some papers have very long cita-
tion lives, whereas others have very short citation 
lives (8,12). The Impact factor favors the latter.
Tenth, the Impact Factor is very easy to manipulate 
and artifi cially infl ate (13). One of the peculiarities 
of the Impact Factor is that the metric contains a 
numerator and a denominator, which do not nec-
essarily include the same article type. Therefore, a 
journal may publish many “Letters to the Editor” or 
“Editorials” with these being citable, or with cita-
tions within them counting towards the Impact Fac-
tor of other articles, but these may not be counted 
as items (not a ‘substantive publication’) for inclu-
sion in the denominator. In essence, this may achieve 
a high number of citable articles within a journal, 
without that same journal appearing to publish a 
high number of substantive publications.
Other drawbacks in the use of the Impact Factor is 
for assigning resources (human or economical) by 
grant-funding bodies, or for measuring (and com-
paring) the success of scientists, despite the fact 
that it has been specifi cally designed for journals 
and not for individual articles or scientists (14,15).
The relationship between biomedical 
research platforms, article submissions 
and journal citations
The choice of one search engine rather than an-
other may be infl uenced by a variety of (mostly) 
personal factors, e.g., the more familiarity with one 
system than with another, the personal or institu-
tional accessibility to research platforms with lim-
Biochemia Medica 2012;22(1):7–14
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ited access, customizable performances and out-
put, as well as the graphic layout. Several studies 
were carried out to assess which among the diff er-
ent biomedical research platforms performs bet-
ters in terms of search output by using objective 
criteria. When Markus compared the four most 
popular search engines (i.e., PubMed/Medline, 
SciVerse/ScienceDirect, Scopus and Google Schol-
ar to assess which is most eff ective for literature re-
search according to three performance criteria (i.e., 
recall, precision and importance), the search fea-
tures provided by PubMed/Medline were reported 
to be exceptional as compared with the other plat-
forms (16). Similar results were obtained by Anders 
and Evans, who found that PubMed/Medline 
searches with clinical queries fi lter were more pre-
cise than with the Advanced Search in Google 
Scholar. The authors also concluded that PubMed/
Medline seems more practical to conduct effi  cient, 
valid searches, for informing evidence-based pa-
tient-care protocols, for guiding the care of indi-
vidual patients, as well as for educational purpos-
es, whereas Google Scholar can only be consid-
ered an adjunct resource, for initial searches to 
quickly fi nd a signifi cant item (17). Although 
PubMed/Medline searches yielded fewer total ci-
tations than Google Scholar according to Freeman 
et al., the former search engine appeared however 
more specifi c than the latter for locating relevant 
primary literature articles (18).
There are several factors that might contribute to 
the success of a journal, where this success is ex-
pressed in terms of citations and thereby Impact 
Factor (Table 3). It is perhaps obvious that the wid-
er the journal coverage, the higher the chance that 
its articles become available to a broader audi-
ence, which could thereby read and then cite 
them. As with most aspects of life, in science, it is 
not so easy to change habits. Several decades ago, 
the only handy system for gathering biomedical 
information was represented by going to a medi-
cal library, consulting the heavy tomes of Index 
Medicus, fi nding the journal articles most repre-
sentative of that topic in the library shelves and fi -
nally photocopying this material for later use. The 
greatest breakthrough has therefore been repre-
sented by the Internet, beginning as soon as re-
search engines became available for that platform. 
Scientists have thereby become accustomed for 
more than a decade to use Medline (now PubMed, 
available to the public since 1995) for retrieving in-
formation, which has been the only reliable source 
along with in EMBASE/Excerpta Medica until new 
tools such as Scopus SciVerse and Google Scholar 
have become available at the dawn of the new mil-
lennium (19). Although the prediction of citation 
would require nothing less than an effi  cient crystal 
ball due to the nature and dynamics of citations 
(20), it has already been demonstrated that e-pub-
lishing increases substantially the citations, espe-
cially when the papers are freely available on the 
web (21), and journals may therefore further in-
crease their Impact Factor by electronic publication 
of contents. Interestingly, Curti et al. carried out a 
retrospective study to verify whether the impact 
factor of a specifi c journal may be related to the 
amount of information available through the Web, 
and found that the presence of the Table of Content 
(TOC), abstract and full text on the Internet was sig-
nifi cantly associated with higher impact factor, even 
after accounting for time and subject category (22). 
Similar results were reported by Mueller (23) and 
Murali (24), who observed that journals available as 
full text on the Web had higher median Impact Fac-
tors than those whose full text was unavailable. 
Moreover, journals that became at least partially 
available online had signifi cant increases in median 
Impact Factors from over 12 years. For example, fi ve 
Brazilian journals that had been indexed by ISI for at 
least fi ve years and available in SciELO for at least 
two more than doubled their Impact Factors since 
inclusion in the latter database (25).
Another important issue that aff ects the citation 
rate is the language of publication, especially for 
Leading factors associated with a higher Impact Factor
Widespread availability on the Web in electronic format.• 
Indexing in the most popular, prominent and accessed • 
biomedical research platforms (e.g., PubMed/MEDLINE, 
Scopus and Google Scholar).
English language of publication of the items.• 
Availability of (free) full text articles on-line.• 
Availability of abstract or summary on-line.• 
Submission from authors with high reputation.• 
Publication of a high number of review articles.• 
TABLE 3. Leading factors associated with a higher Impact Factor.
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journal such as Biochemia Medica, which now ac-
cepts and publishes only manuscripts in the Eng-
lish language, accompanied by abstract in Croatian 
(3). For example, Mueller et al. reported that Eng-
lish-language journals have a greater mean Impact 
Factor than non-English journals and U.S. journals 
have a signifi cantly greater impact factor than 
journals from other Countries, even though the 
mean Impact Factor of English-language U.S. jour-
nals does not diff er from that of English-language 
journals from outside the U.S. (26).
As regards the number of submissions, it is under-
standable that authors tend to submit more arti-
cles to journals that are indexed in international 
databases. According to the always valid maxima 
“..it is better to be looked over than overlooked”, the 
“state of uncitedness” can dramatically decrease 
the number of contributions submitted to a jour-
nal (27). Blank et al. carried out an original research, 
aimed at assessing the impact of SciELO and 
Medline indexing on the number of articles sub-
mitted to the “Jornal de Pediatria”. The data was 
clustered in four periods, stage I (pre-journal web-
site availability); II (journal website availability); III 
(SciELO indexing) and IV (Medline indexing). A sig-
nifi cant trend increase in the number of submis-
sions, especially from foreign countries, was ob-
served throughout the study period, with the 
number of manuscripts submitted rising from 184 
in stage I, 240 in stage II, 297 in stage III, to 482 in 
stage IV (28). The combination of higher interna-
tional visibility and foreign submissions is particu-
larly eff ective in increasing the citations rate, as re-
cently emphasized for by Kovacic and Misak for 
another Croatian journal. The authors calculated 
the Impact Factor of the Croatian Medical Journal 
(CMJ) including the years before indexing into the 
ISI database, and found that the Impact Factor val-
ue nearly doubled over that period. It is notewor-
thy that the leading factors accounting for the in-
crease were the better international visibility, full 
text free-of-charge online availability, along with 
the larger number of international contributions 
(29). Since authors with high reputation, who dis-
proportionately receive more citations than lesser-
known authors, tend to submit their articles to 
high-Impact Factor, Medline-Indexed journals, it is 
inconceivable that these two requisites fundamen-
tally infl uence journal rankings. A fi nal, well recog-
nized factor that contributes to greatly increase ci-
tations and thereby Impact Factor of individual 
journals is publication of large numbers of reviews 
rather than original articles, since reviews typically 
receive higher numbers of citations (30).
Conclusions
Despite a very poor evolution since the 1996, 
PubMed/Medline is still probably one of the pre-
ferred source for scientists, physicians, medical 
students and academics, accounting for by over 
3.5 million searches per day, i.e., 40 per second. Al-
though Web of Science is probably the single most 
used database by U.S. science researchers (i.e., 
42%), PubMed/MEDLINE is at the second place 
(22%) and - even more interestingly - is the pre-
ferred tool for biologists (39%), ahead of Web of 
Science (35%) and Google Scholar (18%) (31). At 
variance with other search engines, PubMed/
Medline (along with Google Scholar) can be ac-
cessed for free and off ers optimal update frequen-
cy, including online early articles. Globally, Google 
Scholar and Scopus/SciVerse provide more cover-
age than Web of Science and PubMed/MEDLINE, 
but they also yield results of inconsistent accuracy 
(32). Therefore, PubMed is still probably the bench-
mark in biomedical electronic research and, in-
deed, Biochemia Medica will without doubt benefi t 
from being indexed in this infl uential research 
platform.
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Biomedicinske istraživačke platforme i njihov odnos s brojem zaprimljenih članaka i 
vrednovanje kvalitete časopisa
Sažetak
Nakon što je Biochemia Medica prihvaćena za indeksiranje u citatnim bazama EMBASE/Excerpta Medica i Scopus, a potom i u Science Citation 
Index Expanded i Journal Citation Reports/Science Edition 2006. godine, Časopis 2010. godine pokreće i novu mrežnu stranicu i on-line sustav za 
prihvaćanje i obradu članaka. Iste je godine Časopis proslavio i svoj prvi čimbenik utjecaja (engl. impact factor, IF). Krajem 2011. Časopis je uvršten 
u citatnu bazu PubMed/Medline što će pridonijeti njegovoj povećanoj vidljivosti i omogućiti pristup čitateljima diljem svijeta. Ovo je značajno 
dostignuće, koje će najvjerojatnije uvjetovati porast popularnosti časopisa, broja zaprimljenih članaka i broja citata.
Trenutno je dostupno nekoliko mrežnih alata za pretraživanje znanstvenih publikacija, čija se operativnost i temeljne značajke ne razlikuju mno-
go, međutim njihova se funkcionalnost, opseg publikacija, zastupljenost i popularnost mogu značajno razlikovati. Nedavno prihvaćanje Časopisa 
Biochemia Medica za indeksiranje u bazi PubMed/Medline je prilika da čitateljstvo upoznamo s postojećim biomedicinskim istraživačkim platfor-
mama, te o tome kako se oni odnose s brojem zaprimljenih članaka i vrednovanju kvalitete časopisa.
Ključne riječi: čimbenik utjecaja; indeksiranje; Medline
